News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4.
Redcare Pharmacy N.V. reports impressive 32% sales growth in 2024, reaching EUR 2.4bn, with Germany's Rx sales soaring 142% in Q4. Active customer base grows to 12.5M -
-
-
COMMUNIQUÉ DE PRESSE
Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.
Redcare Pharmacy reports strong Q3 growth with 2% adj. EBITDA margin. Rx sales surge by over 130% in Germany. Total Group sales up 21% in Q3 to EUR 575M -
-
